MeSH Review:
Cholestasis
Kubitz,
Sütfels,
Kühlkamp,
Kölling,
Häussinger,
Vogel,
Aslan,
Willenbring,
Klein,
Finegold,
Mount,
Thomas,
Grompe,
Kelly,
Nathanson,
Burgstahler,
Mennone,
Dranoff,
Rios-Velez,
Alvarez,
Jara,
Sánchez-Sabaté,
Hierro,
Larrauri,
Díaz,
Camarena,
De la Vega,
Frauca,
López-Collazo,
Lapunzina,
- Ondansetron for pruritus due to cholestasis. Raderer, M., Müller, C., Scheithauer, W. N. Engl. J. Med. (1994)
- Vasculopathic hepatotoxicity associated with E-Ferol syndrome in low-birth-weight infants. Bove, K.E., Kosmetatos, N., Wedig, K.E., Frank, D.J., Whitlatch, S., Saldivar, V., Haas, J., Bodenstein, C., Balistreri, W.F. JAMA (1985)
- Manganese toxicity in children receiving long-term parenteral nutrition. Fell, J.M., Reynolds, A.P., Meadows, N., Khan, K., Long, S.G., Quaghebeur, G., Taylor, W.J., Milla, P.J. Lancet (1996)
- Effect of phenobarbital in a case of extrahepatic cholestasis. Metreau, J.M., Bismuth, H., Franco, D., Dhumeaux, D. Gastroenterology (1975)
- Intestinal failure-associated liver disease: what do we know today? Kelly, D.A. Gastroenterology (2006)
- A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Bull, L.N., van Eijk, M.J., Pawlikowska, L., DeYoung, J.A., Juijn, J.A., Liao, M., Klomp, L.W., Lomri, N., Berger, R., Scharschmidt, B.F., Knisely, A.S., Houwen, R.H., Freimer, N.B. Nat. Genet. (1998)
- Ketoconazole to reduce the need for cyclosporine after cardiac transplantation. Keogh, A., Spratt, P., McCosker, C., Macdonald, P., Mundy, J., Kaan, A. N. Engl. J. Med. (1995)
- Improved neurologic function after long-term correction of vitamin E deficiency in children with chronic cholestasis. Sokol, R.J., Guggenheim, M.A., Iannaccone, S.T., Barkhaus, P.E., Miller, C., Silverman, A., Balistreri, W.F., Heubi, J.E. N. Engl. J. Med. (1985)
- Structural basis for bile acid binding and activation of the nuclear receptor FXR. Mi, L.Z., Devarakonda, S., Harp, J.M., Han, Q., Pellicciari, R., Willson, T.M., Khorasanizadeh, S., Rastinejad, F. Mol. Cell (2003)
- Bilirubin kinetics in intact rats and isolated perfused liver. Evidence for hepatic deconjugation of bilirubin glucuronides. Gollan, J., Hammaker, L., Licko, V., Schmid, R. J. Clin. Invest. (1981)
- Postnatal physiologic hypercholemia in both premature and full-term infants. Barnes, S., Berkowitz, G., Hirschowitz, B.I., Wirtschafter, D., Cassady, G. J. Clin. Invest. (1981)
- Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia. Uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase and chylomicron remnant removal in human fibroblasts, lymphocytes, and in the rat. Walli, A.K., Seidel, D. J. Clin. Invest. (1984)
- Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver. Bossard, R., Stieger, B., O'Neill, B., Fricker, G., Meier, P.J. J. Clin. Invest. (1993)
- Stimulation of bile duct epithelial secretion by glybenclamide in normal and cholestatic rat liver. Nathanson, M.H., Burgstahler, A.D., Mennone, A., Dranoff, J.A., Rios-Velez, L. J. Clin. Invest. (1998)
- Adrenergic regulation of glycogenolysis in rat liver after cholestasis. Modulation of the balance between alpha 1 and beta 2 receptors. Aggerbeck, M., Ferry, N., Zafrani, E.S., Billon, M.C., Barouki, R., Hanoune, J. J. Clin. Invest. (1983)
- Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases. Vogel, A., Aslan, J.E., Willenbring, H., Klein, C., Finegold, M., Mount, H., Thomas, G., Grompe, M. Gastroenterology (2006)
- A controlled trial of D-penicillamine therapy in primary biliary cirrhosis. Jain, S., Scheuer, P.J., Samourian, S., McGee, J.O. Lancet (1977)
- Type III procollagen peptide: a marker of disease activity and prognosis in primary biliary cirrhosis. Babbs, C., Smith, A., Hunt, L.P., Rowan, B.P., Haboubi, N.Y., Warnes, T.W. Lancet (1988)
- Cholestasis confers resistance to the rat liver mitochondrial permeability transition. Lieser, M.J., Park, J., Natori, S., Jones, B.A., Bronk, S.F., Gores, G.J. Gastroenterology (1998)
- The metabolism of 3alpha, 7alpha, 12alpha-trihydorxy-5beta-cholestan-26-oic acid in two siblings with cholestasis due to intrahepatic bile duct anomalies. An apparent inborn error of cholic acid synthesis. Hanson, R.F., Isenberg, J.N., Williams, G.C., Hachey, D., Szczepanik, P., Klein, P.D., Sharp, H.L. J. Clin. Invest. (1975)
- Effect of cholestasis and bile acids on interferon-induced 2',5'-adenylate synthetase and NK cell activities. Podevin, P., Calmus, Y., Bonnefis, M.T., Veyrunes, C., Chereau, C., Poupon, R. Gastroenterology (1995)
- Tetracycline-induced bile duct paucity and prolonged cholestasis. Hunt, C.M., Washington, K. Gastroenterology (1994)
- MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Rosmorduc, O., Hermelin, B., Poupon, R. Gastroenterology (2001)
- Cholestasis: Pump failure, microvilli defect, or both? Erlinger, S. Lancet (1978)
- Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis. Quattropani, C., Vogt, B., Odermatt, A., Dick, B., Frey, B.M., Frey, F.J. J. Clin. Invest. (2001)
- Trafficking of the bile salt export pump from the Golgi to the canalicular membrane is regulated by the p38 MAP kinase. Kubitz, R., Sütfels, G., Kühlkamp, T., Kölling, R., Häussinger, D. Gastroenterology (2004)
- Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. Gaudio, E., Barbaro, B., Alvaro, D., Glaser, S., Francis, H., Ueno, Y., Meininger, C.J., Franchitto, A., Onori, P., Marzioni, M., Taffetani, S., Fava, G., Stoica, G., Venter, J., Reichenbach, R., De Morrow, S., Summers, R., Alpini, G. Gastroenterology (2006)
- Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. Stedman, C.A., Liddle, C., Coulter, S.A., Sonoda, J., Alvarez, J.G., Moore, D.D., Evans, R.M., Downes, M. Proc. Natl. Acad. Sci. U.S.A. (2005)
- Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1. Alvarez, L., Jara, P., Sánchez-Sabaté, E., Hierro, L., Larrauri, J., Díaz, M.C., Camarena, C., De la Vega, A., Frauca, E., López-Collazo, E., Lapunzina, P. Hum. Mol. Genet. (2004)
- Metronidazole in prevention of cholestasis associated with total parenteral nutrition. Capron, J.P., Gineston, J.L., Herve, M.A., Braillon, A. Lancet (1983)
- Effect of cholestasis produced by bile duct ligation on hepatic heme and hemoprotein metabolism in rats. Schacter, B.A., Joseph, E., Firneisz, G. Gastroenterology (1983)
- Loss of inositol 1,4,5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis. Shibao, K., Hirata, K., Robert, M.E., Nathanson, M.H. Gastroenterology (2003)
- Scanning electron microscopy of the rat liver. Studies of the effect of taurolithocholate and other models of cholestasis. Layden, T.J., Schwarz, n.u.l.l., Boyer, J.L. Gastroenterology (1975)
- Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Cavicchi, M., Beau, P., Crenn, P., Degott, C., Messing, B. Ann. Intern. Med. (2000)